Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Interest Expenses (2021 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Interest Expenses for 6 consecutive years, with $48000.0 as the latest value for Q1 2026.

  • For Q1 2026, Interest Expenses fell 5.88% year-over-year to $48000.0; the TTM value through Mar 2026 reached $203000.0, down 78.85%, while the annual FY2025 figure was $206000.0, 88.09% down from the prior year.
  • Interest Expenses hit $48000.0 in Q1 2026 for Bicycle Therapeutics, down from $57000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $883000.0 in Q2 2022 and bottomed at $33000.0 in Q3 2024.
  • Average Interest Expenses over 5 years is $505352.9, with a median of $814000.0 recorded in 2023.
  • Year-over-year, Interest Expenses surged 56.7% in 2022 and then plummeted 95.95% in 2024.
  • Bicycle Therapeutics' Interest Expenses stood at $826000.0 in 2022, then dropped by 0.73% to $820000.0 in 2023, then crashed by 93.66% to $52000.0 in 2024, then increased by 9.62% to $57000.0 in 2025, then decreased by 15.79% to $48000.0 in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $48000.0, $57000.0, and $44000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.